Stocksigma LogoStocksigma Logo

Bacil Pharma Reports Q2 Standalone Net Loss of ₹0.98 Lakh

Bacil Pharma reported zero operational revenue for the quarter ended 30th Sep'26, generating ₹9.18 lakh in other income compared to ₹8.91 lakh in the

Bacil Pharma Reports Q2 Standalone Net Loss of ₹0.98 Lakh

Bacil Pharma Ltd · Outcome · 14 Oct 2026, 9:41 pm

Bacil Pharma Reports Q2 Standalone Net Loss of ₹0.98 Lakh Bacil Pharma reported zero operational revenue for the quarter ended 30th Sep'26, generating ₹9.18 lakh in other income compared to ₹8.91 lakh in the previous quarter. On a standalone basis, net loss after tax narrowed to ₹0.98 lakh from a loss of ₹1.61 lakh in the quarter ended 30th Jun'26, while total comprehensive income stood at ₹15.29 lakh. Consolidated net loss widened to ₹7.22 lakh. For the half year ended 30th Sep'26, total income fell sharply to ₹18.09 lakh from ₹105.74 lakh YoY.

Original exchange filing (PDF)

More announcements from Bacil Pharma Ltd

All Bacil Pharma Ltd announcements